Abstract: New tryptamine 5, 7 and β-carboline derivatives 3 were prepared by palladiumcatalyzed coupling reaction of 5-bromotryptamine 1 with aryl boronic acids.
Introduction
Tryptamine is the fundamental building block of some alkaloids and biogenic amines [1] . For instance, serotonin (5-hydroxytryptamine) is the major neurotransmitter which regulates mood, appetite, sleep, and self-control [2, 6] . Its inhibitor effectively treats anxiety symptoms associated with depression [7, 8] . Due to their remarkable chemical and biological importance, novel tryptamine derivatives are desired products. So, it was worthwhile to develop a new synthetic method for the preparation of 5-substituted tryptamine derivatives.
For the preparation of desired tryptamine derivatives, we used the Suzuki-type coupling reaction, which is presently one of the most powerful and versatile tools for aryl-aryl coupling. The reaction takes place between an aryl boronic acid and aryl halide, and is catalyzed by a tetraphosphane-palladium complex [9] [10] [11] [12] [13] [14] [15] .
Results and discussion
Treatment of a mixture of bromotryptamine 1 (1 equiv) and phenylboronic acid (2a, 1.2 equiv) with catalytic amounts of palladium complex [Pd(OAc) 2 [(o-tolyl) 3 P] 2 , 0.05 equiv] and aqueous Na 2 CO 3 (2 equiv) afforded an unexpected product. On the bases of IR, NMR, and mass spectral data, tetrahydro-β-carboline structure 3a was assigned to this compound. The formation of 3a can be imagined via two steps: the expected cross coupling reaction followed by (or with simultaneous) or simultaneous intramolecular cyclisation (Scheme 1). Under similar conditions, the palladium catalyzed reactions between bromotryptamine 1 and boronic acids 2b-e also gave β-carboline derivatives 3b-e ( Table 1 ). The efficiency of these reactions was dependent on the substituent(s) of boronic acid. Namely, the yields increased substantially with increasing electron-withdrawing character of the substituent.
To avoid the cyclization reaction, we protected the free amino group of tryptamine 1 with acylation. The N-chloroacetyl derivative 4 were then subjected to coupling reaction with boronic acids 2a-e. Under similar conditions as above, the palladium catalyzed reaction yielded tryptamine derivatives 5a-e in acceptable yields.
Likewise, tryptamine 1 was acylated with 2-hydroxybenzoyl chloride and product 6 coupled with boronic acids 2. The palladium catalyzed reaction afforded tryptamine derivatives 7a-e in moderate yields (Table 1) .
In summary, we conclude the described method is suitable for the preparation of new class of tryptamine and β-carboline derivatives. These new compounds are of biological and medicinal interest. 
Experimental
Solvents were used as received from commercial vendors and no further attempts were made to purify or dry them. Mps were determined on a Büchi apparatus and are uncorrected. IR spectra were recorded on Zeiss Specord M 80 spectrometer. 1 H and 13 C NMR spectra were obtained on a Bruker DRX-500 spectrometer. All NMR spectra are reported in ppm relative to TMS. MS measurements were carried out on a VG-TRIO-1000 GC/MS instrument. Only selected peaks from the infrared and mass spectra are quoted. Merck precoated silica gel 60 F 254 plates were used for TLC and Kieselgel 60 for column chromatography. Solvents were mixed on a v/v basis.
Boronic acids 2 and palladium catalyst were received from Sigma-Aldrich without purification prior to use. All compounds gave satisfactory spectral data (IR, 1 H and 13 C NMR and MS) and elemental analyses.
Tetrahydro-1H-β-carboline 3; General Procedure To a stirred suspension of tryptamine 1 (0.3 g, 0.96 mmol) in 1,2-dimethoxyethane (30 mL) was added successively arylboronic acid 2 (1.2 equiv), Pd(OAc) 2 (11 mg, 5 mol %), tri-o-tolylphosphine (29 mg, 10 mol %), aquos Na 2 CO 3 solution (0.2 g, 2 equiv) and the resulting mixture was stirred and heated to reflux under Ar, for the time indicated in Table 1 . After cooling, the reaction mixture was dried (MgSO 4 ), filtered, and the solvent was evaporated in vacuo. The residue was subjected to preparative TLC (silica gel 60 PF 254+366 ; MeOH-CH 2 Cl 2 1:10 as eluent).
To a stirred suspension of tryptamine 4 (0.2 g, 0.5 mmol) in 1,2-dimethoxyethane (30 mL) was added successively arylboronic acid 2 (1.2 equiv), Pd(OAc) 2 (6 mg, 5 mol %), tri-o-tolylphosphine (16 mg, 10 mol %), aquos Na 2 CO 3 solution (0.11 g, 2 equiv) and the resulting mixture was stirred and heated to reflux under Ar, for the time indicated in Table 1 . After cooling, the reaction mixture was dried (MgSO 4 ), filtered, and the solvent was evaporated in vacuo. The residue was subjected to preparative TLC (silica gel 60 PF 254+366 ; CH 2 Cl 2 -EtOAc-MeOH 10:2:0.2 as eluent).
To a stirred suspension of tryptamine 1 (1 g, 3.2 mmol) in CH 2 Cl 2 (70 mL) was added Et 3 N (0.94 mL, 6.7 mmol) and a solution of chloroacetyl-chloride (0.3 mL, 3.8 mmol) in CH 2 Cl 2 (5 mL). The resultant mixture was stirred at room temperature for 24 h and then washed with 0.1 N HCl (3x20 mL) followed by water. The organic layer was dried (MgSO 4 ), filtered, and concentrated in vacuo. The residue was washed with cold CH 2 Cl 2 to give title compound (0.85 g, 69 %). White solid, m.p.: 180
• C IR (KBr): 3352, 1696, 1668, 1560, 1248, 1104 cm 3 .32 (2H, q,J = 6 Hz, C 2' -H), 3.97 (2H, s, C 5' -H), 4.35 (2H, q, J= 7 Hz, OCH 2 ), 7.36 (2H, d, J= 9 Hz, C 6 -H), 7.38 (1H, J= 9 Hz, C 7 -H), 7.90 (1H, s, C 4 -H), 8.26 (1H, t, J= 5 Hz, NH), 11.78 (1H, s, NH). 
